Mechanisms of Immunosuppression in Colorectal Cancer
CRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While s...
Main Authors: | Yang Zhang, Ashwani Rajput, Ning Jin, Jing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3850 |
Similar Items
-
The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
by: David J. Hermel, et al.
Published: (2019-01-01) -
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
by: Yan Tie, et al.
Published: (2022-05-01) -
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
by: Weiqiang Lu, et al.
Published: (2021-01-01) -
Efficacy and Safety of Fruquintinib Combined with Sintilimab in Treatment of Advanced Microsatellite Stable Colorectal Cancer
by: LI Shan, et al.
Published: (2023-12-01) -
Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study
by: Caiyun Nie, et al.
Published: (2022-09-01)